Homozygous Familial Hypercholesterolemia research hub

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

This study is testing a new medicine, zodasiran, for people aged 12 and over with a serious inherited condition called homozygous familial hypercholesterolemia (HoFH). It aims to see if zodasiran safely and effectively lowers very high cholesterol levels.